JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 4, 2007; DOI: 10.1124/jpet.106.116145


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.116145v1
321/1/202    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Minsavage, G. D.
Right arrow Articles by Dillman III, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Minsavage, G. D.
Right arrow Articles by Dillman III, J. F.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*2-PHENYLETHANOL
*BIS(2-CHLOROETHYL)SULFIDE
*MECHLORETHAMINE
Medline Plus Health Information
*Antioxidants


Received for publication October 25, 2006.
Revised January 2, 2007.
Accepted for publication January 2, 2007.

BIFUNCTIONAL ALKYLATING AGENT-INDUCED p53 AND NONCLASSICAL NUCLEAR FACTOR-KAPPA B (NF-{kappa}B) RESPONSES AND CELL DEATH ARE ALTERED BY CAFFEIC ACID PHENETHYL ESTER (CAPE): A potential role for antioxidant/electrophilic response element (ARE/EpRE) signaling

Gary D. Minsavage 1 James F. Dillman III 1*

1 U.S. Army Medical Research Institute of Chemical Defense

* Address correspondence to: E-mail: james.dillman{at}us.army.mil

Abstract

Bifunctional alkylating agents (BFAs) such as mechlorethamine (nitrogen mustard; NM) and bis-(2-chloroethyl) sulfide (sulfur mustard; SM) covalently modify DNA and protein. The roles of NF-{kappa}B and p53, transcription factors involved in inflammatory and cell death signaling, were examined in normal human epidermal keratinocytes (NHEKs) and immortalized HaCaT keratinocytes, a p53-mutated cell line, to delineate molecular mechanisms of action of BFAs. NHEKs and HaCaT cells exhibited classical NF-{kappa}B signaling as degradation of I{kappa}B{alpha} occured within 5 min after exposure to tumor necrosis factor-alpha. However, exposure to BFAs induced nonclassical NF-{kappa}B signaling as loss of I{kappa}B{alpha} was not observed until 2 or 6 hr in NHEKs or HaCaT cells, respectively. Exposure of a NF-{kappa}B reporter gene-expressing HaCaT cell line to 12.5, 50, or 100 µM SM activated the reporter gene within 9 hr. Pretreatment with caffeic acid phenethyl ester (CAPE), a known inhibitor of NF-{kappa}B signaling, significantly decreased BFA-induced reporter gene activity. A 1.5-hr pretreatment or 30-min post-exposure treatment with CAPE prevented BFA-induced loss of membrane integrity by 24 hr in HaCaT cells but not in NHEKs. CAPE disrupted BFA-induced phosphorylation of p53 and p90RSK in both cell lines. CAPE also increased Nrf2 and decreased AhR protein expression, both of which are involved in antioxidant/electrophilic response element (ARE/EpRE) signaling. Thus, disruption of p53/p90RSK-mediated NF-{kappa}B signaling and activation of ARE/EpRE pathways may be effective strategies to delineate mechanisms of action of BFA-induced inflammation and cell death signaling in immortalized versus normal skin systems.


Key words: NF-kappaB, alkylating agents, antioxidant/electrophilic response element, caffeic acid phenethyl ester, mustards, p53





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.